BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20698732)

  • 1. Prevention and treatment of no-reflow.
    Niccoli G; Marino M; Spaziani C; Crea F
    Acute Card Care; 2010 Sep; 12(3):81-91. PubMed ID: 20698732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus.
    Sharma S; Lardizabal JA; Singh S; Sandhu R; Bhambi BK
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):152-9. PubMed ID: 22559269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No-reflow: Still searching for that magic bullet.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):794. PubMed ID: 21104769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardial no-reflow phenomenon: recent knowledges].
    Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
    Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the no-reflow phenomenon.
    Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
    Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial no-reflow in humans.
    Niccoli G; Burzotta F; Galiuto L; Crea F
    J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
    Ahmed TA; Atary JZ; Wolterbeek R; Hasan-Ali H; Abdel-Kader SS; Schalij MJ; Jukema JW
    J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and predictive factors.
    Romano M; Buffoli F; Lettieri C; Aroldi M; Tomasi L; Baccaglioni N; Rosiello R; Zanini R
    Minerva Cardioangiol; 2005 Feb; 53(1):7-14. PubMed ID: 15788976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial 'no-reflow' prevention.
    Magro M; Springeling T; van Geuns RJ; Zijlstra F
    Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
    OchaƂa A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M
    Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Dudek D; Sardella G; Marino P; Chevalier B; Zijlstra F
    Eur Heart J; 2008 Dec; 29(24):3002-10. PubMed ID: 18775918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and physical prevention and treatment of no-reflow after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Guo AQ; Sheng L; Lei X; Shu W
    J Int Med Res; 2013 Jun; 41(3):537-47. PubMed ID: 23628920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention and the no-reflow phenomenon.
    van Gaal WJ; Banning AP
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.
    De Luca G; Suryapranata H; Marino P
    Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspiration thrombectomy with primary PCI for STEMI: review of the data and current guidelines.
    Brodie BR
    J Invasive Cardiol; 2010 Oct; 22(10 Suppl B):2B-5B. PubMed ID: 20947929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.